Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chia-Chi Flora Huang

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Genome Research|June 10, 2025
Comprehensive functional annotation of ESR1-driven enhancers in breast cancer reveals hierarchical activity independent of genomic and epigenomic contextsYanis Zekri, Sebastian Gregoricchio, Elif Yapıcı, et al.
Biochemistry|September 22, 2015
Uncovering the Mechanism of Forkhead-Associated Domain-Mediated TIFA Oligomerization That Plays a Central Role in Immune ResponsesJui-Hung Weng, Yin-Cheng Hsieh, Chia-Chi Flora Huang, et al.
Biorxiv : the Preprint Server for Biology|November 14, 2023
Breast cancer risk SNPs converge on estrogen receptor binding sites commonly shared between breast tumors to locally alter estrogen signalling outputStacey Ep Joosten, Sebastian Gregoricchio, Suzan Stelloo, et al.
Cancers|July 24, 2021
Development of an Androgen Receptor Inhibitor Targeting the N-Terminal Domain of Androgen Receptor for Treatment of Castration Resistant Prostate CancerFuqiang Ban, Eric Leblanc, Ayse Derya Cavga, et al.
Molecular and Cellular Biology|May 9, 2012
Intermolecular binding between TIFA-FHA and TIFA-pT mediates tumor necrosis factor alpha stimulation and NF-κB activationChia-Chi Flora Huang, Jui-Hung Weng, Tong-You Wade Wei, et al.
Genome Research|May 8, 2024
Estrogen receptor 1 chromatin profiling in human breast tumors reveals high inter-patient heterogeneity with enrichment of risk SNPs and enhancer activity at most-conserved regionsStacey E P Joosten, Sebastian Gregoricchio, Suzan Stelloo, et al.
Cancer Research|January 11, 2017
Aurora A and NF-κB Survival Pathway Drive Chemoresistance in Acute Myeloid Leukemia via the TRAF-Interacting Protein TIFATong-You Wade Wei, Pei-Yu Wu, Ting-Jung Wu, et al.
Communications Biology|February 5, 2025
Identification of selective SWI/SNF dependencies in enzalutamide-resistant prostate cancerBengul Gokbayrak, Umut Berkay Altintas, Shreyas Lingadahalli, et al.
Journal of Medicinal Chemistry|October 18, 2021
Development of 2-(5,6,7-Trifluoro-1<i>H</i>-Indol-3-yl)-quinoline-5-carboxamide as a Potent, Selective, and Orally Available Inhibitor of Human Androgen Receptor Targeting Its Binding Function-3 for the Treatment of Castration-Resistant Prostate CancerEric Leblanc, Fuqiang Ban, Ayse Derya Cavga, et al.
Nature Genetics|September 7, 2022
Genetic determinants of chromatin reveal prostate cancer risk mediated by context-dependent gene regulationSylvan C Baca, Cassandra Singler, Soumya Zacharia, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Genome Research|June 10, 2025
Comprehensive functional annotation of ESR1-driven enhancers in breast cancer reveals hierarchical activity independent of genomic and epigenomic contextsYanis Zekri, Sebastian Gregoricchio, Elif Yapıcı, et al.
Biochemistry|September 22, 2015
Uncovering the Mechanism of Forkhead-Associated Domain-Mediated TIFA Oligomerization That Plays a Central Role in Immune ResponsesJui-Hung Weng, Yin-Cheng Hsieh, Chia-Chi Flora Huang, et al.
Biorxiv : the Preprint Server for Biology|November 14, 2023
Breast cancer risk SNPs converge on estrogen receptor binding sites commonly shared between breast tumors to locally alter estrogen signalling outputStacey Ep Joosten, Sebastian Gregoricchio, Suzan Stelloo, et al.
Cancers|July 24, 2021
Development of an Androgen Receptor Inhibitor Targeting the N-Terminal Domain of Androgen Receptor for Treatment of Castration Resistant Prostate CancerFuqiang Ban, Eric Leblanc, Ayse Derya Cavga, et al.
Molecular and Cellular Biology|May 9, 2012
Intermolecular binding between TIFA-FHA and TIFA-pT mediates tumor necrosis factor alpha stimulation and NF-κB activationChia-Chi Flora Huang, Jui-Hung Weng, Tong-You Wade Wei, et al.
Genome Research|May 8, 2024
Estrogen receptor 1 chromatin profiling in human breast tumors reveals high inter-patient heterogeneity with enrichment of risk SNPs and enhancer activity at most-conserved regionsStacey E P Joosten, Sebastian Gregoricchio, Suzan Stelloo, et al.
Cancer Research|January 11, 2017
Aurora A and NF-κB Survival Pathway Drive Chemoresistance in Acute Myeloid Leukemia via the TRAF-Interacting Protein TIFATong-You Wade Wei, Pei-Yu Wu, Ting-Jung Wu, et al.
Communications Biology|February 5, 2025
Identification of selective SWI/SNF dependencies in enzalutamide-resistant prostate cancerBengul Gokbayrak, Umut Berkay Altintas, Shreyas Lingadahalli, et al.
Journal of Medicinal Chemistry|October 18, 2021
Development of 2-(5,6,7-Trifluoro-1<i>H</i>-Indol-3-yl)-quinoline-5-carboxamide as a Potent, Selective, and Orally Available Inhibitor of Human Androgen Receptor Targeting Its Binding Function-3 for the Treatment of Castration-Resistant Prostate CancerEric Leblanc, Fuqiang Ban, Ayse Derya Cavga, et al.
Nature Genetics|September 7, 2022
Genetic determinants of chromatin reveal prostate cancer risk mediated by context-dependent gene regulationSylvan C Baca, Cassandra Singler, Soumya Zacharia, et al.
Pageof 2